A phase III clinical study to compare the immunogenicity and safety of the 9-valent and quadrivalent HPV vaccines in men
Under a Creative Commons license
open access
Abbreviations
9vHPV vaccine
9-valent HPV vaccine
AE
adverse event
ANOVA
analysis of variance
CI
confidence interval
cLIA
competitive Luminex immunoassay
EU
European Union
GMTs
geometric mean titres
HPV
human papilloma virus
qHPV vaccine
quadrivalent HPV vaccine
SAE
serious adverse event
USA
United States of America
VLP
virus-like particle
VRC
vaccination report card
Keywords
Human papilloma virus
Anogenital cancers
Anogenital warts
Immunogenicity
Safety
Nine-valent human papilloma virus vaccine
Cited by (0)
© 2016 The Authors. Published by Elsevier Ltd.